Kang Chen

11PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 05, 2026
Stress Hyperglycemia Drives CD4+ T Cell PANoptosis and Postoperative Organ Injury via Monocyte-Derived Succinate.

|Jun 15, 2026
Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells.

|Jun 03, 2026
IFN-γ PET imaging stratifies and predicts response to CD137 agonism in a syngeneic colorectal tumor model.

|Apr 24, 2026
IgD from atypical-like memory B cells and plasma cells targets commensal and environmental antigens.

|Nov 18, 2025
Author Correction: Not marginal but central: type I interferons unleash marginal zone B cells in Sjögren's disease.

Alice Werynski, Chun-Xiao Li, Yujing Hao

|Oct 28, 2025
Not marginal but central: type I interferons unleash marginal zone B cells in Sjögren's disease.

Alice Werynski, Chun-Xiao Li, Yujing Hao

Pageof 2

Frequent Collaborators

2 joint publications

Giuliana Magri

2 joint publications

Andrea Cerutti

2 joint publications

Ruping Dai

2 joint publications

Hui Li